首页> 外文学位 >Retrospective study of prevalence of Community Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) seen in Texas MedClinics, San Antonio, TX from April 2006-August 2009.
【24h】

Retrospective study of prevalence of Community Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) seen in Texas MedClinics, San Antonio, TX from April 2006-August 2009.

机译:回顾性研究2006年4月至2009年8月在得克萨斯州圣安东尼奥市的得克萨斯医学诊所中观察到的社区耐甲氧西林金黄色葡萄球菌(CA-MRSA)患病率。

获取原文
获取原文并翻译 | 示例

摘要

Purpose. To evaluate the presence of Community Associated--Methicillin Resistant Staphylococcus Aureus, CA-MRSA, in abscesses and skin and soft tissue infections presenting at 9 urgent care clinics in San Antonio, TX.;Methods. During the 40-month retrospective study (April 2006 to August 2009), wound cultures collected in 9 urgent care centers were evaluated for MRSA growth, antibiotics prescribed, follow up wound care, and antibiotic prescribing habits by physicians for all patients presenting with abscesses and skin/soft tissue infections.;Results. Across 9 urgent care centers in San Antonio, TX, 36,797 abscesses and cases of skin and soft tissue infections were treated during 40 months. Of the 36,797 cases, 9290 patients had wound cultures sent with 5,630 cultures sent to Texas MedClinic's primary lab. Of the 5630 cultures sent to their primary lab, this reflected a prevalence of 4727 (84 %) cultures were positive for MRSA. Of the 9290 patients who had a wound culture sent (April 10th, 2006 to August 31st, 2009), a total of 4,307 antibiotics were prescribed. The top five antibiotics prescribed for CA-MRSA were Bactrim (55.5%), Clindamycin (18.4%), Bactroban (5%), Amoxicillin (3.5%), and Doxycycline (3%) representing 85.4% of the antibiotics prescribed. 8809/9290 (94.8%) of patients required no more than 3 follow up visits. Of the 33 physicians working full time during the entire study period, 29/33 (87.8%) of the physicians were family medicine physicians and represented varied prescribing rates of antibiotics between 11-76% with 26/33 (78.8%) of physicians prescribing antibiotics greater than 40% of the time.;Conclusions. Abscesses and soft tissue infections are a common presenting complaint to urgent care centers. This study reveals that antibiotic-prescribing practices can be improved with physician education since this high prevalence was not known previously. Also, treating abscesses with limited packing has been shown to be a viable option in this particular circumstance and would be open field for additional clinical research. Due to the high prevalence of CA-MRSA skin and soft tissue infections among patients presenting to urgent care centers presumptive treatment for MRSA is indicated. Increasing levels of resistance to penicillin antibiotics is concerning and warrants alternative antibiotic management strategies.
机译:目的。评估在德克萨斯州圣安东尼奥市9家急诊诊所出现的脓肿,皮肤和软组织感染中社区耐药甲氧西林金黄色葡萄球菌CA-MRSA的存在;方法。在为期40个月的回顾性研究(2006年4月至2009年8月)中,医师对所有脓肿和脓肿患者进行了评估,评估了9个急诊中心收集的伤口培养物的MRSA生长,处方的抗生素,伤口的随访护理以及抗生素的处方习惯。皮肤/软组织感染。在德克萨斯州圣安东尼奥市的9个紧急护理中心中,有40个月治疗了36,797例脓肿,并治疗了皮肤和软组织感染病例。在这36,797例病例中,有9290例患者接受了伤口培养,其中有5,630例培养物被发送至Texas MedClinic的主要实验室。在送往其主要实验室的5630种培养物中,这反映出4727(84%)种培养的MRSA阳性率。在9290名接受伤口培养的患者中(2006年4月10日至2009年8月31日),共开出了4,307种抗生素的处方。针对CA-MRSA的前五种抗生素为Bactrim(55.5%),克林霉素(18.4%),Bactroban(5%),阿莫西林(3.5%)和强力霉素(3%),占处方抗生素的85.4%。 8809/9290(94.8%)患者需要进行的随访不超过3次。在整个研究期间,全职工作的33位医生中,有29/33(87.8%)位医生是家庭医学医生,代表的抗生素处方率在11-76%之间,而有26/33(78.8%)位医生处方抗生素的使用率大于40%。脓肿和软组织感染是急诊中心的常见症状。这项研究表明,由于这种高患病率以前是未知的,因此通过医师教育可以改善抗生素处方的使用方法。而且,在这种特殊情况下,用有限的包装来治疗脓肿已被证明是可行的选择,并且对于其他临床研究将是开放的领域。由于在急诊中心就诊的患者中,CA-MRSA皮肤和软组织感染的患病率很高,因此需要对MRSA进行推定治疗。对青霉素抗生素耐药性的提高正在引起关注,并有必要采取其他抗生素管理策略。

著录项

  • 作者

    Boyd, Linda Renee.;

  • 作者单位

    The University of Texas School of Public Health.;

  • 授予单位 The University of Texas School of Public Health.;
  • 学科 Health Sciences Public Health Education.
  • 学位 M.P.H.
  • 年度 2010
  • 页码 46 p.
  • 总页数 46
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:45:45

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号